IL-2 mimetic peptides (AplaGen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIL-2 mimetic peptides (AplaGen)
Drug Alias NameInterleukin-2 peptide mimetics (AplaGen)IL-2 immunomers (AplaGen)AGIL2-03
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAplaGen GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAplaGen GmbH
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A